Search

everythinglearnresearchcommunity

for

Search:↓

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

Anifrolumab significantly improved skin lesions and hair regrowth in severe discoid lupus.

Oral feline interferon-omega improved symptoms in diabetic cats with gingivostomatitis.

COVID-19 can cause various skin issues in children, mostly not severe, with chilblain-like lesions being common, especially in adolescents.

Certain genetic variations in IL18 may increase the risk of alopecia areata in Koreans.

JAK inhibitors are safe and effective for treating moderate-to-severe alopecia areata.

Psoriasis patients are willing to pay less than the cost of biologic treatments for remission and don't expect complete or long-term symptom clearance.

Certain medications can cause serious side effects, so it's important to report them.

Watching, not removing, skin growths with moderate atypia and positive edges is okay; patients may get melanoma elsewhere, especially if they've had it before.

The conclusion is that differentiating wound types in RDEB patients is important for clinical trials and understanding the disease.

Platelet Rich Plasma can potentially help in restoring hair loss, but more research with larger groups is needed to confirm its effectiveness and standardize its use.

Skin disease activity scores can help decide when skin symptoms no longer affect the quality of life in patients with mild dermatomyositis.

In 2002, various drugs caused serious side effects, including vitamin B12 deficiency, heart issues, blindness, hypersexuality, allergic reactions, blood clotting problems, pupil dilation, capillary leak syndrome, muscle breakdown, hepatitis, skin reactions, and lupus.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Ruxolitinib treatment led to unexpected hair regrowth in a patient with alopecia universalis.

2-deoxy D-glucose does not help with hair regrowth in alopecia areata.

COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.

The document suggests a rare skin condition might be caused by a genetic phenomenon.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Topical rosuvastatin and melatonin creams significantly reduce psoriasis severity and are safe.

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.

Imatinib mesylate can cause skin lightening, especially in Chinese patients, due to its effect on pigment production.

A woman with chronic hepatitis C had a rare skin condition linked to her illness.

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Imiquimod may be a better non-surgical treatment for cervical pre-cancer, but its effectiveness for vaginal pre-cancer is unclear, and it has some side effects.

TLR3 signaling enhances the immunosuppressive properties of human periodontal ligament stem cells.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.